Grace L. Guo
Affiliations: | Pharmacology, Toxicology & Therapeutics | University of Kansas, Lawrence, KS, United States |
Area:
Cell Biology, OncologyGoogle:
"Grace Guo"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Henry ZR, Armstrong L, Maliha S, et al. (2025) Deletion of hepatic FXR leads to more severe MASH development in female mice. Hepatology Communications. 9 |
| Basaly V, Bhattacharya A, Guo GL. (2024) Insights of direct and indirect regulation of PXR through phosphorylation in fatty liver disease. Molecular Pharmacology. 107: 100014 |
| Taylor R, Basaly V, Kong B, et al. (2024) Effects of Therapeutically Approved Individual Bile Acids on The Development of Metabolic Dysfunction-Associated Steatohepatitis a Low Bile Acid Mouse Model. Toxicological Sciences : An Official Journal of the Society of Toxicology |
| Jin J, Nguyen LTG, Wassef A, et al. (2024) . Drug Metabolism and Disposition: the Biological Fate of Chemicals |
| Jin J, Nguyen LTG, Wassef A, et al. (2024) Identification and Functional Characterization of Alternative Transcripts of LncRNA HNF1A-AS1 and Their Impacts on Cell Growth, Differentiation, Liver Diseases, and in Response to Drug Induction. Non-Coding Rna. 10 |
| Taylor R, Yang Z, Henry Z, et al. (2024) Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model. Toxicological Sciences : An Official Journal of the Society of Toxicology |
| Yang X, Wang J, Chang CY, et al. (2024) Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia in mice. Nature Communications. 15: 627 |
| Bhattacharya A, Taylor RE, Guo GL. (2023) In vivo mouse models to study bile acid synthesis and signaling. Hepatobiliary & Pancreatic Diseases International : Hbpd Int |
| Meadows V, Yang Z, Basaly V, et al. (2023) FXR Friend-ChIPs in the Enterohepatic System. Seminars in Liver Disease |
| Henry Z, Meadows V, Guo GL. (2023) FXR and NASH: an avenue for tissue-specific regulation. Hepatology Communications. 7 |